Cargando...
Modeling of Cost Effectiveness of Pneumococcal Conjugate Vaccination Strategies in U.S. Older Adults
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) is approved by the U.S. Food and Drug Administration for adults, but its role in older adults is unclear. PURPOSE: To compare PCV13 strategies to currently recommended vaccination strategies in adults aged ≥65 years. METHODS: Using a M...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601581/ https://ncbi.nlm.nih.gov/pubmed/23498103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2012.11.035 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|